Antibacterial dressing for promoting scarless healing of wound surface and method for preparing the same
US-2024350702-A1 · Oct 24, 2024 · US
US9655990B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9655990-B2 |
| Application number | US-201414783081-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 8, 2014 |
| Priority date | Apr 8, 2013 |
| Publication date | May 23, 2017 |
| Grant date | May 23, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to an anti-aging antimicrobial wound healing polymer based hydrogel. In the study of the present invention, a wound healing gel formulation is developed by combining poloxamer polymers and boron component at adequate concentrations in a carbopol based gel. The said gel exhibits fast action on the damaged area and prevents scar formation.
Opening claim text (preview).
The invention claimed is: 1. An anti-aging, wound-healing and antimicrobial hydrogel, which is comprising: 3% boron compound, 4% poloxamer and 1% gel; wherein the boron compound and the poloxamer are added to the gel that is prepared as a carrier, wherein the boron compound is selected from a group consisting of sodium pentaborate pentahydrate, boric acid, alkaline and alkaline earth metal borates and all hydrate forms of these borates, ammonium borates, and boric acid esters. 2. The hydrogel according to claim 1 , wherein the gel comprises carbopol. 3. The hydrogel according to claim 1 , wherein the boron derivative is a sodium pentaborate pentahydrate. 4. The hydrogel according to claim 1 , wherein a mixture of the gel, the boron compound and the poloxamer are stored at 4° C. for 16-24 hours before it can be used. 5. The hydrogel according to claim 1 , wherein the boron compound is a boric acid. 6. The hydrogel according to claim 1 , wherein the boron compound is alkaline metal borates. 7. The hydrogel according to claim 1 , wherein the boron compound is alkaline earth metal borates. 8. The hydrogel according to claim 1 , wherein the form of the hydrogel is selected from a group consisting of lotion, cream, emulsion, spray, foam, gelatin, paste, powder, plaster, skin plate, and wound dressing textile product.
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics · CPC title
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
for treating wounds, ulcers, burns, scars, keloids, or the like · CPC title
Drugs for dermatological disorders · CPC title
Anti-ageing preparations · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.